Active	Status	Sponsor type	Region	Phase	Filter
5 Active 10 Inactive 15 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes: « April » « 2025 » M T W T F S S 31 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 1 2 3 4   - « April » « 2025 » M T W T F S S 31 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 1 2 3 4   Show only changed items Enrollment:

Advanced Filters

5 Trials

Active Trials   

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
Rejnmark, Lars
ZOL PHPT, NCT06859580: Bisphosphonate Prior to Parathyroidectomy in Primary Hyperparathyroidism	Recruiting	4	140	Europe	Zoledronic acid 4 mg, ZOL, Zoledronate, Zoledronate acid, Natriumklorid 9 mg/ml, Fresenius Kabi, saline water	University of Aarhus	Primary Hyperparathyroidism	02/28	02/28
NCT04273490: Characterising Pain, QoL, Body Composition, Arterial Stiffness, Muscles and Bones in Adult Persons With XLH and Healthy Controls	Completed	N/A	92	Europe		University of Aarhus	X-linked Hypophosphatemia, Hereditary Hypophosphatemia	12/22	12/22
CAREHYPO, NCT06419270: Cardiovascular, Renal, and Skeletal Complications in Patients With Post-Surgical Hypoparathyroidism	Recruiting	N/A	100	Europe	Observation	University of Aarhus, Gødstrup Hospital	Hypoparathyroidism, Cardiovascular Complication, Fractures, Bone, Renal Disease	05/26	12/28
XLHRegistry, NCT03193476: Registry for Patients With X-Linked Hypophosphatemia	Recruiting	N/A	1343	Europe, RoW		Kyowa Kirin Pharmaceutical Development Ltd, Iqvia Pty Ltd	X-Linked Hypophosphatemia	02/29	07/29
PARADIGHM, NCT01922440: A Registry for Participants With Chronic Hypoparathyroidism	Active, not recruiting	N/A	1339	Europe, Canada, US	No intervention	Takeda, Takeda Development Center Americas, Inc.	Hypoparathyroidism	11/34	11/34

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
Rejnmark, Lars
ZOL PHPT, NCT06859580: Bisphosphonate Prior to Parathyroidectomy in Primary Hyperparathyroidism	Recruiting	4	140	Europe	Zoledronic acid 4 mg, ZOL, Zoledronate, Zoledronate acid, Natriumklorid 9 mg/ml, Fresenius Kabi, saline water	University of Aarhus	Primary Hyperparathyroidism	02/28	02/28
NCT04273490: Characterising Pain, QoL, Body Composition, Arterial Stiffness, Muscles and Bones in Adult Persons With XLH and Healthy Controls	Completed	N/A	92	Europe		University of Aarhus	X-linked Hypophosphatemia, Hereditary Hypophosphatemia	12/22	12/22
CAREHYPO, NCT06419270: Cardiovascular, Renal, and Skeletal Complications in Patients With Post-Surgical Hypoparathyroidism	Recruiting	N/A	100	Europe	Observation	University of Aarhus, Gødstrup Hospital	Hypoparathyroidism, Cardiovascular Complication, Fractures, Bone, Renal Disease	05/26	12/28
XLHRegistry, NCT03193476: Registry for Patients With X-Linked Hypophosphatemia	Recruiting	N/A	1343	Europe, RoW		Kyowa Kirin Pharmaceutical Development Ltd, Iqvia Pty Ltd	X-Linked Hypophosphatemia	02/29	07/29
PARADIGHM, NCT01922440: A Registry for Participants With Chronic Hypoparathyroidism	Active, not recruiting	N/A	1339	Europe, Canada, US	No intervention	Takeda, Takeda Development Center Americas, Inc.	Hypoparathyroidism	11/34	11/34